STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration
Jing Chen, Shuting Huang, Huawen Li, Yun Li, Haishan Zeng, Jiemei Hu, Yanchun Lin, Huihua Cai, Pengfei Deng, Ting Song, Tian Guan, Haoyu Zeng, Mubiao Liu
Topics & Concepts
MedicineEndometrial cancerViability assayCancer researchCervical cancerCancerWestern blotOncologyCancer cellClinical trialCellInternal medicineBiologyGeneticsBiochemistryGeneCytokine Signaling Pathways and InteractionsCancer Cells and MetastasisImmune cells in cancer